Search for another bill

Search for another bill or initiative


SB 5594 - 2025-26

Revised for engrossed: Concerning biosimilar medicines and interchangeable biological products.
Original: Concerning biosimilar medicines.

Bill status-at-a-glance

As of Tuesday, February 17, 2026 04:35 AM

Current version:

2nd engrossed substitute - 2ESSB 5594

Current status:

HHC/Wellness

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamberIn the Senate:In the House:
After passage:PassedLegislatureOn Governor'sdeskGovernoractedSession law

Bill status-at-a-glance

As of Tuesday, February 17, 2026 04:35 AM

Current version:

2nd engrossed substitute - 2ESSB 5594

Current status:

HHC/Wellness

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamber
Senate:
House:
PassedLegislatureOn Governor'sdeskGovernoractedSession law
AfterPassage:

Bill history

2025 Regular Session

In the Senate

Jan 30
First reading, referred to Health & Long-Term Care. (View original bill)
Feb 11
Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM. (Committee materials)
Feb 18
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM. (Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass. (View 1st substitute) (Majority report)
Feb 19
Passed to Rules Committee for second reading.
Mar 5
Placed on second reading by Rules Committee.
Mar 11
1st substitute bill substituted (HLTC 25). (View 1st substitute)
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (View 1st engrossed) (View this roll call)

In the House

Mar 13
First reading, referred to Health Care & Wellness.
Mar 26
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee materials)
Apr 1
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee materials)
Apr 27
By resolution, returned to Senate Rules Committee for third reading.

2026 Regular Session

In the Senate

Jan 12
By resolution, reintroduced and retained in present status.
Jan 19
Rules Committee relieved of further consideration.
Placed on third reading.
Jan 21
Rules suspended.
Returned to second reading for amendment.
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (View 2nd engrossed) (View this roll call)

In the House

Jan 26
First reading, referred to Health Care & Wellness.
Feb 10
Public hearing in the House Committee on Health Care & Wellness at 8:30 AM. (Committee materials)

Available documents

For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.

Fiscal note

Amendments

Available videos